US Patent Issued to Board of Regents, The University of Texas System on Feb. 3 for "Imidazopiperazine inhibitors of transcription activating proteins" (Texas Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,139, issued on Feb. 3, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Imidazopiperazine inhibitors of transcription activating proteins" was invented by Kang Le (Sugar Land, Texas), Michael J. Soth (Sugar Land, Texas), Philip Jones (Houston), Jason Bryant Cross (Pearland, Texas) and Timothy Joseph McAfoos (Pearland, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of transcription activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory d...